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Background and PurposezzIt is particularly difficult to differentiate dementia with Lewy 
bodies (DLB) from the related dementias of Alzheimer’s disease (AD) and Parkinson’s disease de-
mentia (PDD). Few studies have been designed to comparatively analyze detailed neuropsycho-
logical assessments of DLB patients and patients with AD and PDD.
MethodszzThree groups of patients participated in this study: 10 with DLB, 76 with AD, and 17 
with PDD, who had been diagnosed as probable DLB, AD, and PDD, respectively, according to 
the clinical criteria of the consortium on DLB, National Institute of Neurological and Communi-
cative Diseases and Stroke/Alzheimer’s Disease and Related Disorder Association, and the clini-
cal diagnostic criteria for PDD. All patients were evaluated by careful neurological examination 
with detailed neuropsychological testing.
ResultszzSignificant differences among the three groups were found for attention, memory, and 
executive function, which included tasks of backward digit span, three-word recall, verbal delayed 
recall, and the Stroop test. Post hoc analysis revealed that the deficiencies of attention on the digit 
span task were greater in the DLB group than in the AD and PDD groups. The scores for episodic 
verbal memory tasks were significantly lower in the DLB and AD groups than in the PDD group. 
The performance in frontal executive function, as indicated by the Stroop test, was significantly 
worse in the DLB and PDD groups than in the AD group.
ConclusionszzThe results of the present study show that the pattern of cognitive dysfunction, in 
terms of attention, episodic memory, and executive functions, differ between patients with DLB 
and patients with AD and PDD.  J Clin Neurol 2011;7:19-24
Key Wordszz  dementia with lewy bodies, Alzheimer’s disease, Parkinson’s disease dementia, 
cognition, neuropsychology.
Introduction
Alzheimer’s disease (AD) and idiopathic Parkinson’s disease 
(PD) are the most common age-related neurodegenerative dis-
orders. The parkinsonian feature is a relatively common sign in 
clinically diagnosed AD, and cognitive impairment is also 
quite common in PD.
1,2 Dementia with Lewy bodies (DLB), 
which is characterized by progressive dementia and fluctuating 
cognition and is associated with visual hallucination and Parkin-
sonism, has recently emerged as one of the most common neu-
rodegenerative dementias.
3,4 DLB has now been identified as a 
separate disease, although it remains difficult to differentiate it 
from the related dementias of AD and PD dementia (PDD).
5 
DLB should be considered as a probable diagnosis in patients 
showing dementia in the early stage of Parkinsonism. Unlike 
PD, the clinical presentation of DLB demonstrates progressive 
cognitive decline, with significant deficits of visuospatial abil-
ity as well as loss of frontal executive function, accompanied 
by mild-to-moderate Parkinsonism.
6,7 In attempts to differenti-
ate DLB from other dementias, several studies have suggested 
the use of cognitive assessment to differentiate patients with 
DLB from those with AD or PDD.
8-12
The importance of neuropsychological testing for DLB is be-
ing increasingly emphasized: careful cognitive assessments 
with clinical work-up are becoming the fundamental standards, 
providing basic information and guidelines for the appropriate Cognitive Profiles of DLB vs. AD and PDD
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treatment of patients with DLB. Few studies have been desig-
ned to comparatively analyze detailed neuropsychological as-
sessments of DLB patients and AD and PDD.
9-11
Some studies have found that DLB and PDD patients per-
form significantly worse on attentional functions and better on 
memory tests than AD patients,
9,10 and that DLB patients exhibit 
lower scores than AD patients on visual memory and visuospa-
tial tests. No significant differences have been noted between 
PDD and DLB subjects on any neuropsychological test. How-
ever, others found that DLB patients performed worse than 
PDD patients with regard to frontal executive function and vi-
sual recognition memory.
13
In the present study we used neuropsychological evaluation 
to determine whether cognitive deficits differ between patients 
with DLB and those with either AD or PDD. The aims of this 
study were to determine the pattern of cognitive impairment in 
DLB and to differentiate DLB from AD and PDD using com-
prehensive neuropsychological testing.
Methods
Subjects
We consecutively enrolled 10 patients diagnosed with probable 
DLB, 76 patients with probable AD, and 17 patients with prob-
able PDD. They were recruited sequentially between June 2006 
and May 2009 from the dementia and PD clinics at a universi-
ty hospital. They were diagnosed as probable DLB, AD, or PDD 
respectively according to the following three sets of clinical cri-
teria: 1) the clinical criteria of the consortium on DLB,
4 2) the 
diagnostic criteria for AD from the National Institute of Neuro-
logical and Communicative Diseases and Stroke/Alzheimer’s 
Disease and Related Disorder Association,
14 and 3) the clinical 
diagnostic criteria for PDD.
15 The following exclusion criteria 
were applied:
1) Major depression, bipolar disorder, schizophrenia, or sub-
stance-use disorder.
2) Cerebrovascular disease, hydrocephalus, or brain tumor 
documented by structural imaging within the previous 12 
months.
3) Deficiency of serum folate and vitamin B12, neurosyphilis, 
or clinically significant thyroid disease.
4) A history of traumatic brain injury.
5) Significant medical illnesses (e.g., poorly controlled diabetes 
or hypertension, cancer within the previous 5 years, clinically sig-
nificant hepatic, renal, cardiac, or pulmonary disorders).
All patients were carefully evaluated by a neurologist and a 
neuropsychologist. Recruited subjects showing a severe state of 
dementia who were unable to participate in detailed neuropsy-
chological evaluations were excluded. Patients with PDD who 
showed motor fluctuations were assessed in the “ON” phase. 
We avoided periods of any confusion or drowsiness during neu-
ropsychological evaluation in DLB patients. Subjects were not 
taking cholinesterase inhibitors or memantine during the peri-
od of neuropsychological evaluation. Patients with DLB and 
PDD were evaluated while on their medications of levodopa or 
dopamine agonist.
The evaluation procedure comprised a detailed medical his-
tory, physical and neurological examinations, neuropsychologi-
cal assessments, appropriate laboratory tests, and a brain MRI. 
Histories of medical and neurological problems were obtained 
from the patient and their family members or other caregivers. 
Informed consent to participate in this study was obtained from 
all patients, and the study was approved by the Institutional 
Review Board of the hospital.
Neuropsychological assessment
The general cognitive status and severity of dementia were ev-
aluated using the Korean Mini-Mental State Examination (K-
MMSE),
16,17 the clinical dementia rating (CDR),
18 and the sum 
of the box score of the CDR (CDRSB). The scores for physical 
activities of daily living were estimated using the Barthel activ-
ities of daily living (B-ADL) index.
All patients underwent the standardized neuropsychological 
test battery of the Seoul Neuropsychological Screening Bat-
tery,
19 which includes the following tests:
1) Attention: forward and backward digit span and letter can-
cellation test.
2) Language and related functions: reading, writing, compre-
hension, repetition, and confrontational naming using the Ko-
rean version of the Boston Naming Test,
20 finger naming, right-
left orientation, body part identification, calculation, and ideo-
motor and buccofacial praxis.
3) Visuospatial function test: interlocking pentagon drawing 
and the Rey Complex Figure Test (RCFT).
4) Verbal memory test: three-word registration and recall, 
and Seoul Verbal Learning Test.
5) Visual memory test: the RCFT, immediate recall, 20-min 
delayed recall, and recognition.
6) Frontal executive function test: motor impersistence, con-
trasting program, go/no-go test, fist-edge-palm test, alternating 
hand movement, alternating square and triangle, Luria loop, se-
mantic (animals and supermarket) and phonemic Controlled 
Oral Word Association Test, and the Stroop test (word and col-
or reading of 112 items).
Statistical analysis
The clinical and baseline characteristics of the patients are 
summarized using descriptive statistics. A Fisher’s exact chi-
square test was used to compare categorical variables between 
groups, while an analysis of covariance was used to compare Park KW et al.
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continuous variables. Response variables were adjusted for 
CDR, B-ADL, K-MMSE, and CDRSB, and adjusted means 
were compared between the groups with the Tukey-Kramer 
post hoc test. Plots of the mean±SD values are presented. 
The level of statistical significance was set at p<0.05. All statis-
tical analyses were carried out using SAS version 9.1.3 and 
R 2.9.1 statistical software.
Results
Demographic characteristics
The demographic characteristics and cognitive functions, to-
gether with the daily functional and behavioral scales of the 
patients with DLB, AD, and PPD are presented in Table 1. 
There were no significant differences between the patient 
groups with regard to sex, age, educational level, or in general 
cognitive measures as indicated by K-MMSE, CDR, and CD-
RSB scores. The geriatric depression scales did not differ sig-
nificantly between the three groups. However, with regard to 
the functional scales of Barthel activities of daily living (B-
ADL), the post hoc comparisons indicated that the impair-
ment in the basic activities of daily living was greater in the 
PDD group than in the AD group (p<0.05).
Neuropsychological findings
Comparison of the neuropsychological differences between pa-
tients with DLB, AD, and PDD is summarized in Table 2. anal-
ysis of covariance revealed significant differences among the 
Table 1. Demographic data and general cognitive functions with 
daily activities in the three patient groups
DLB 
(n=10)
AD 
(n=76)
PDD 
(n=17)
p
Gender, n (%), female 5 (50%) 50 (66%) 13 (76%) 0.42
Age (years) 70.4±8.8 71.7±7.8 68.5±5.0 0.15
Education (years) 8.4±4.4 6.2±5.1 4.8±5.0 0.12
K-MMSE 20.2±3.9 19.8±3.0 21.8±3.2 0.056
CDR 1.0±0.4 0.8±0.3 0.6±0.2 0.055
CDRSB 4.9±2.6 4.6±1.9 3.5±2.1 0.083
GDS 20.7±3.9 19.3±7.5 21.6±6.7 0.53
B-ADL 17.7±2.7 19.5±1.1 16.9±4.1 0.0002
AD: alzheimer’s disease, B-ADL: Barthel activities of daily living, 
CDR: Clinical Dementia Rating, CDRSB: Clinical Dementia Rating 
Sum of Boxes, DLB: dementia with Lewy bodies, GDS: Geriatric De-
pression Scale, K-MMSE: Korean version of the Mini-Mental State 
Examination, PDD: parkinson’s disease dementia.
Table 2. Adjusted scores* of neuropsychological test in the three patient groups (mean±SD values)
Test DLB (n=10) AD (n=76) PDD (n=17) p Post hoc comparison
Attention
Digit span: forward 05.0±1.4 04.8±1.4 04.7±1.8 0.92 NA
Digit span: backward 01.6±1.1 02.6±1.1 02.5±1.5 0.039 DLB<AD=PDD
Language Function
K-BNT 25.2±11.2 30.2±10.2 31.6±16.8 0.38 NA
Visuospatial Function
RCFT 15.5±10.7 21.2±10.9 16.5±14.6 0.26 NA
Memory
Three-word recall 01.0±0.8 00.7±0.8 01.7±1.1 0.004 DLB=AD, DLB=PDD, AD<PDD
SVLT
Immediate recall 09.3±3.7 10.6±3.8 11.5±4.9 0.40 NA
20-min delayed recall 01.1±1.6 00.8±1.6 03.0±2.1 0.001 AD=DLB<PDD
Recognition: true positive-false positive 09.1±3.2 07.5±3.3 09.8±4.2 0.11 NA
RCFT
Immediate recall 04.0±4.1 03.0±4.2 02.9±6.1 0.76 NA
20-min delayed recall 04.8±4.6 04.5±4.7 03.2±6.7 0.37 NA
Recognition: true positive–false positive 07.1±3.8 06.6±3.9 07.3±5.3 0.88 NA
Frontal –executive function
COWAT: animals 07.6±2.9 07.8±2.9 09.8±3.8 0.13 NA
COWAT: supermarket 09.2±3.8 07.6±3.7 10.0±4.8 0.16 NA
COWAT: phonemic 02.5±7.4 08.0±7.5 09.8±11.8 0.078 NA
Stroop: word reading 42.5±31.5 85.8±31.8 71.5±51.7 0.002 DLB<AD=PDD
Stroop: color reading 15.5±24.6 38.9±24.2 24.0±40.1 0.031 DLB=PDD, AD=PDD, DLB<AD
*Scores were adjusted for CDR, B-ADL, K-MMSE, and CDRSB.
AD: Alzheimer’s disease, COWAT: Controlled Oral Word Association Test, DLB: dementia with lewy bodies, K-BNT: Korean version of the Bos-
ton Naming Test, NA: Not applicable, PDD: Parkinson’s disease dementia, RCFT: Rey Complex Figure Test, SVLT: Seoul Verbal Learning Test.Cognitive Profiles of DLB vs. AD and PDD
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three groups in the cognitive domains of attention, memory, 
and frontal executive function, which included tasks of back-
ward digit span, three-word recall, verbal delayed recall, and 
the Stroop test. The post hoc analysis showed that the deficit in 
attention on the task of digit span was greater in the DLB 
group than in the AD and PDD groups (Table 2, Fig. 1). The 
DLB and AD groups achieved significantly lower scores than 
the PDD group in verbal memory function, on delayed recall 
of Seoul Verbal Learning Test, and on the task of three-word 
recall (Table 2, Fig. 2). Frontal executive function, as indicat-
ed by the word reading of the Stroop test, was significantly 
worse in the DLB group than in the AD and PDD groups (Ta-
ble 2, Fig. 3). The score on the task of color reading of the 
Stroop test was significantly lower in the DLB group than in 
the AD group (Table 2, Fig. 3). Although the Controlled Oral 
Word Association Test scores did not differ significantly be-
tween the DLB, AD, and PDD groups, the score for the task 
of phonemic word fluency was lower in the DLB group than 
in the AD and PDD groups. Visuospatial function on the 
RCFT did not differ significantly between the three groups. 
Moreover, the scores for verbal and visual recognition did not 
differ significantly between patients with DLB and PDD.
Discussion
The present study investigated the characteristics of cognitive 
profiles of patients with DLB and attempted to differentiate 
DLB from AD and PDD by using comprehensive neuropsy-
chological assessments, which covered a wide range of cogni-
tive domains. It is very important to be able to differentiate be-
tween the cognitive profiles of DLB sufferers and those with 
AD and PDD. The distinctive patterns of neuropsychological 
dysfunction observed in these dementias probably represent a 
different distribution of pathological changes. The neuropatho-
logical substrate of AD affects predominantly the medial tem-
poral cortex and the neocortical association areas, which ex-
plains the predominant dysfunction of episodic memory fun-
ction. On the other hand, the neuropathological basis of DLB 
includes neuronal loss and the presence of Lewy bodies in the 
subcortical nucleus and in the frontal and parietal lobes, which 
explains the predominantly attentional, executive, and visuo-
spatial dysfunctions.
21 Recent clinical pathological data have 
demonstrated that DLB and PDD patients have the same un-
derlying pathology of the Lewy body spectrum.
22,23 Most PDD 
patients may indeed show clinical features and neuropsycho-
logical characteristics that are similar to those exhibited by 
DLB patients.
Fig. 1. Neuropsychological comparison of the attention domain in 
the three patient groups. Values are mean and SE values; bars with 
different superscripts differ from each other within a specific catego-
ry (p<0.05). Means with the same letter in their superscripts do not 
differ significantly from one another according to a Tukey-Kramer 
test with a 0.05 limit on the familywise error rate. AD: Alzheimer’s 
disease, DLB: dementia with lewy bodies, PDD: Parkinson’s dis-
ease dementia.
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Fig. 2. Neuropsychological comparison of the verbal memory do-
main in the three patient groups. Data are mean and SE values; 
bars with different superscripts differ from each other within a spe-
cific category (p<0.05). Means with the same letter in their super-
scripts do not differ significantly from one another according to a Tu-
key-Kramer test with a 0.05 limit on the familywise error rate. AD: 
Alzheimer’s disease, DLB: dementia with lewy bodies, PDD: Parkin-
son’s disease dementia.
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Fig. 3. Neuropsychological comparison of executive function domain 
in the three patient groups. Data are mean and SE values; bars with 
different superscripts differ from each other within a specific cate-
gory (p<0.05). Means with the same letter in their superscripts do 
not differ significantly from one another according to a Tukey-Kram-
er test with a 0.05 limit on the familywise error rate. AD: Alzheim-
er’s disease, DLB: dementia with lewy bodies, PDD: Parkinson’s dis-
ease dementia.
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Our results showed that verbal memory function in DLB is 
comparable with that in AD. Unlike previous studies,
9,10,24 the 
degree of impairment in the episodic memory tests was the 
same in our DLB and AD patients. The discrepancies between 
the results of our study and those of prior studies
9,10,24 may be 
explained by several factors. First, the K-MMSE scores were 
lower in our patients than in those included in previous stud-
ies.
9,10 Thus, the floor effect, in items of memory function, may 
have occurred in both DLB and AD patients. Second, both DLB 
and AD are often linked to degeneration in the medial tempo-
ral lobes, including the hippocampus and amygdala. Hamilton 
et al.
11,25 suggested that the poor memory function in DLB pa-
tients is attributable to an encoding impairment rather than the 
consolidation defect. Third, despite our attempt to exclude mix-
ed pathologies of DLB and AD, some patients with concomi-
tant DLB and AD were included in our study sample.
Our findings are consistent with those of previous studies in 
showing that the frontal executive function is much worse in 
DLB than in AD.
9-12 The findings of the current study reflect a 
different distribution of neuropathological changes in DLB, 
which include widespread neuronal loss with the presence of 
Lewy bodies in the subcortical nuclei, and the frontal subcor-
tical association and dorsolateral areas of the frontal lobe. The 
Stroop test is widely used for evaluating executive function and 
is considered to measure impairments in the dorsolateral pre-
frontal system. The results of the Stroop test in the present study 
suggest that the circuit associated with color reading is fre-
quently disrupted in patients with DLB, with these interrup-
tions occurring in the dorsolateral prefrontal lobe.
Unlike the results of previous studies,
9,10,26,27 our data re-
vealed that visuospatial function on RCFT did not differ sig-
nificantly between the DLB and PDD patients and the AD 
patients. The current results show that the patients with DLB 
and PDD had lower scores for K-MMSE and lower educa-
tional levels than the participants in previous studies,
9,10 sug-
gesting that these factors influenced their performance on the 
RCFT. The scores for visuospatial function on the RCFT tend-
ed to be lower scores in the DLB and PDD groups than in the 
AD group.
In the present study we found differences between DLB and 
PDD patients, which contrasts with the findings of previous 
studies.
9,10,13,28 The deficits in the cognitive domains of atten-
tion, memory, and executive function were greater in our DLB 
patients than our PDD patients. However, visual recognition 
scores did not differ between these two groups.
In a comparison of the cognitive profiles of patients with 
PDD and those with DLB, the MMSE scores of whom indi-
cated a mild stage of dementia, Aarsland et al.
9 and Downes et 
al.
28 demonstrated that executive function was impaired more 
in patients with DLB than in those with PDD. The K-MMSE 
scores of our patients indicated a mild stage of dementia, and 
the performance for attention, executive function, and verbal 
memory was worse in those with DLB than in those with PDD. 
These data suggest that although PDD and DLB share similar 
global cognitive patterns, the cognitive deficits in the frontal and 
medial temporal-related cognitive functions during the mild sta-
ges of dementia are greater in patients with DLB than in PDD 
patients. It is suggested that the distribution of Lewy body pa-
thology differs between PDD and DLB patients in the early dis-
ease stage. There is also evidence that the presence of amyloid 
pathology differs between DLB and PDD.
29,30 Demonstration 
of a significant amyloid pathology in [11C] Pittsburgh com-
pound B positron-emission tomography might explain why the 
level of deterioration in memory and executive functions is 
higher in DLB than in PDD. A very recent study found that a 
subgroup of PDD patients not experiencing cognitive fluctua-
tions showed significantly less attentional, executive, and me-
mory deficits compared to those with DLB and PDD experienc-
ing cognitive fluctuations.
31 The differences in cognitive profiles 
between DLB and PDD in our data may be influenced by the 
discrepancy of distribution in the two subgroups of PDD.
There present study was subject to some shortcomings. First, 
selection bias may have been present in our sample because the 
patients were recruited either through a memory clinic or th-
rough a PD clinic. In addition, the results of our study are lim-
ited by the disproportionate numbers of AD patients and DLB 
and PDD patients. Second, we cannot be certain about the ac-
curacy of our clinical diagnoses because of the lack of neuro-
pathological confirmation. Although we attempted to exclude 
cases with suspected mixed pathology, some of the patients 
with DLB may have had concomitant AD. Third, the neuro-
psychological assessment tool utilized herein is not fully ade-
quate to ascertain the detailed characteristics of several cogni-
tive domains.
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